Lv4
452 积分 2025-04-17 加入
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
3天前
已完结
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing
3天前
已完结
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
3天前
已完结
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
4天前
已完结
Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
8天前
已完结
Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies
8天前
已完结
Precision-Engineered CD3 T-Cell Engagers for Solid Tumours: Conditional Activation, Microenvironment Modulation, and Clinical Translation
8天前
已完结
Innovative strategies for T cell engagers for cancer immunotherapy
8天前
已完结
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
9天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
15天前
已完结
皖公网安备34019202002308
